Neogen Corporation (NEOG)
Neogen Corporation at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.
Neogen Corporation (NEOG) is a Medical - Diagnostics & Research company based in US with a market capitalization of $2B. Revenue declined 3.2% year-over-year and free cash flow was negative at -$46.4M. This page tracks NEOG's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.
US · 2.92K employees · IPO Aug 23, 1989
Valuation
Valuation & price
$8.19as of May 17, 2026· -27.7% vs 52w high
—
P/E ratio
Latest-FY diluted EPS
0.97
P/B ratio
Market cap ÷ book equity
—
Dividend yield
Price — last 12 months
Fundamentals
Key fundamentals
$2B
Market cap
-3.2%
Revenue growth (YoY)
47.1%
Gross margin
-$46.4M
Free cash flow (USD)
$783.6M
Net debt
0.2%
Share dilution
3/5
Graham criteria passed
Defensive-investor screen
Healthcare
Sector
Trajectory
Long-term trends
Revenue by year
2016 → 2025
Free cash flow by year
2016 → 2025
Gross margin by year
2021 → 2025
Value screen
Graham defensive-investor tests
0
Insider buys · 90 days
0
Insider sells · 90 days
Earnings
Last report: 10-Q filed Apr 9, 2026
Next expected: not yet scheduled
On the tape
Recent SEC & insider activity
Questions
Frequently asked questions
What is Neogen Corporation's market cap?
Neogen Corporation (NEOG) has a market capitalization of $2B.
What is NEOG's P/E ratio?
A meaningful P/E ratio is not available for NEOG — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.
What is NEOG's price-to-book (P/B) ratio?
NEOG trades at 0.97 times book value per share.
Are insiders buying NEOG stock?
SEC Form 4 filings show no open-market insider buys at Neogen Corporation in the last 90 days (0 sells).
Same arena
Related companies in Medical - Diagnostics & Research
Timeline
Every filing, insider trade & earnings on a price-anchored timeline
Filing Analyzer
Search the actual 10-K / 10-Q text with AI research angles
News
Latest press coverage in one feed
Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.